ELTX
ELTX
NASDAQ · Biotechnology

Elicio Therapeutics Inc

$10.66
-0.03 (-0.28%)
As of Apr 1, 10:08 PM ET ·
Financial Highlights (FY 2025)
Revenue
32.29M
Net Income
4.35M
Gross Margin
63.7%
Profit Margin
13.5%
Rev Growth
+12.6%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 63.7% 63.7% 63.7%
Operating Margin 17.2% 18.7% 17.9%
Profit Margin 13.5% 18.0% 13.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 32.29M 31.67M 27.66M
Gross Profit 20.57M 20.17M 17.61M
Operating Income 5.55M 5.92M 4.96M
Net Income 4.35M 5.71M 3.74M
Gross Margin 63.7% 63.7% 63.7%
Operating Margin 17.2% 18.7% 17.9%
Profit Margin 13.5% 18.0% 13.5%
Rev Growth +12.6% +22.6% -0.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 22.74M 20.95M 24.25M
Total Equity 120.34M 113.52M 121.07M
D/E Ratio 0.19 0.18 0.20
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.33M 8.25M 7.51M
Free Cash Flow 3.02M 4.79M 4.27M